Education
About Us
Working with TipRanks
Follow Us
Lifestance Health Group (LFST)
NASDAQ:LFST
Earnings Data
Report Date
May 07, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.01Last Year’s EPS
-0.06Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 27, 2025
|% Change Since: -7.46%
|Next Earnings Date:May 07, 2025
Earnings Call Sentiment|Positive
LifeStance Health displayed strong overall financial performance with significant revenue and EBITDA growth, alongside operational achievements and a successful leadership transition. However, they face challenges with flat rate expectations due to payer negotiations and increased G&A expenses. Overall, the highlights outweigh the lowlights.Company Guidance
During the LifeStance Health Fourth Quarter 2024 Earnings Call, the company exceeded all guided metrics, achieving a 19% revenue growth to $1.25 billion and a 103% increase in adjusted EBITDA to $120 million, resulting in a 9.6% margin. They provided nearly 8 million visits to about 1 million patients with a clinician base of over 7,400. Their patient Net Promoter Score improved to 85, with Google reviews averaging 4.6 out of 5. The company aims for 2025 revenue between $1.4 billion and $1.44 billion, and adjusted EBITDA between $130 million and $150 million. They anticipate flat total revenue per visit for the year and project a return to low to mid-single digit annual rate improvements by 2026. Additionally, LifeStance plans to open 25 to 30 new centers in 2025, while maintaining a focus on organic growth.Strong Financial Performance
LifeStance Health reported a 19% revenue growth to $1.25 billion for the full year 2024, with adjusted EBITDA up 103% to $120 million, representing a 9.6% margin.
Operational and Clinical Achievements
LifeStance provided nearly 8 million visits to 1 million patients with a team of over 7,400 clinicians. The company received a patient Net Promoter Score of 85 and an average Google review score of 4.6 out of 5 stars.
Positive Cash Flow and Debt Refinancing
LifeStance generated $86 million in positive free cash flow, a significant achievement ahead of expectations. They also refinanced existing debt with favorable terms, reducing the credit spread to 2.25%.
Leadership Transition
Dave Bourdon will succeed Ken Burdick as CEO, with Ken transitioning to Executive Chairman. Ryan McGroarty has been appointed as the new CFO.
---
LFST Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
LFST Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 27, 2025 | $7.51 | $7.74 | +3.06% |
| Nov 07, 2024 | $7.13 | $7.68 | +7.71% |
| Aug 08, 2024 | $5.51 | $5.93 | +7.62% |
| May 09, 2024 | $6.98 | $7.12 | +2.01% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Lifestance Health Group (LFST) report earnings?
Lifestance Health Group (LFST) is schdueled to report earning on May 07, 2025, TBA Not Confirmed.
What is Lifestance Health Group (LFST) earnings time?
Lifestance Health Group (LFST) earnings time is at May 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LFST EPS forecast?
LFST EPS forecast for the fiscal quarter 2025 (Q1) is -0.01.
---